Login / Signup

A prospective, randomized study of Toremifene vs. tamoxifen for the treatment of premenopausal breast cancer: safety and genital symptom analysis.

Jin HongJiahui HuangLili ShenSiji ZhuWeiqi GaoJiayi WuOu HuangJianrong HeLi ZhuWeiguo ChenYafen LiXiaosong ChenKunwei Shen
Published in: BMC cancer (2020)
ClinicalTrials.gov NCT02344940. Registered 26 January 2015 (retrospectively registered).
Keyphrases
  • postmenopausal women
  • combination therapy
  • breast cancer risk
  • estrogen receptor
  • replacement therapy
  • early breast cancer